Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources ; day:15 ; month:7 ; year:2016 ; pages:1-16
Rheumatology and therapy ; (15.7.2016), 1-16
- Creator
-
Monemi, Sharareh
- Contributor
-
Berber, Erhan
Sarsour, Khaled
Wang, Jianmei
Lampl, Kathy
Bharucha, Kamal
Pethoe-Schramm, Attila
SpringerLink (Online service)
- DOI
-
10.1007/s40744-016-0037-z
- URN
-
urn:nbn:de:1111-2016071924785
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Monemi, Sharareh
- Berber, Erhan
- Sarsour, Khaled
- Wang, Jianmei
- Lampl, Kathy
- Bharucha, Kamal
- Pethoe-Schramm, Attila
- SpringerLink (Online service)
Other Objects (12)
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Active immunization with Tocilizumab mimotopes induces specific immune responses
Else Gabriel, Auto-Perforations-Artist
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Active immunization with Tocilizumab mimotopes induces specific immune responses
Else Gabriel, Auto-Perforations-Artist
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
Colonic carcinoma with multiple small bowel perforations mimicking intestinal obstruction
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study
Vision loss in patients with giant cell arteritis treated with tocilizumab
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Active immunization with Tocilizumab mimotopes induces specific immune responses